Chinese pharmaceutical firm CGeneTech has raised over RMB100 million (US$14.52 million) in a series A+ round of financing led by Hongtai Capital, a venture capital firm co-established by the founder of Chinese education giant New Oriental Education.
Hongtai Capital Leads $14M Series A+ Round In Chinese Pharmaceutical Firm comes originally from China Money Network This news article comes via China Money Network, who is the copyright owner of this information and news. FintekAsia.com has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of
